Clinical Trials Logo
  1. Home
  2. Other
  3. NCT05906628

Topical Ruxolitinib Evaluation in Chronic Hand Eczema

Hand Eczema Clinical Trial

Official title:
A Phase 2, Double-Blind, Randomized, 16-Week, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream Followed by an Open-Label Extension Period in Adults With Chronic Hand Eczema

Clinical Trial Summary

The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in adult participants with diagnosis of chronic hand eczema (CHE) and moderate to severe disease activity (Investigator's Global Assessement (IGA) of CHE score 3 or 4).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05906628
Study type Interventional
Source Incyte Corporation
Contact
Status Active, not recruiting
Phase Phase 2
Start date July 31, 2023
Completion date January 17, 2025
View Details
See also
  Status Clinical Trial Phase
Completed NCT00576550 - A Randomised Trial of a Moisturising Cream in Preventing Recurrence of Hand Eczema Phase 4
Completed NCT00404196 - LEO19123 Cream in the Treatment of Hand Eczema Phase 2
Completed NCT05763914 - A 24-week Single-blind Trial of Prevention of Hand Eczema in Cleaners N/A
Recruiting NCT03026946 - Alitretinoin vs Cyclosporine in Severe Recurrent Vesicular Hand Eczema Phase 3
Recruiting NCT03026907 - Alitretinoin vs Azathioprine in Severe Non-hyperkeratotic Hand Eczema Phase 3
Completed NCT00488241 - Multicenter Clinical Study to Examine the Efficacy and Safety of Zarzenda in Patients With Hand Eczema Phase 4
Terminated NCT01826630 - A Study to Assess CLn® BodyWash for Reducing Skin Fauna in Patients With Hand Eczema N/A
Recruiting NCT04449575 - Hand Eczema in the Health Care Sector
Withdrawn NCT05219864 - Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 1 Phase 3
Completed NCT01591785 - Treatment of Staphylococcus Aureus Colonization in Hand Eczema N/A
Completed NCT00826592 - Comparison of Video-Based Versus Written Patient Education on Atopic Dermatitis N/A
Completed NCT02664805 - Proof of Concept, Twice Daily Applications of LEO 124249 Ointment in the Treatment of Chronic Hand Eczema Phase 2
Completed NCT05471934 - Satisfaction Survey - Cicaplast Mains
Active, not recruiting NCT04512339 - Dupilumab in Severe Chronic Hand Eczema Phase 2
Completed NCT04375410 - Consequences of Intensified Handwash and Hand Disinfection Among Children During the COVID19 Pandemic